Health Care · Surgical & Medical Instruments & Apparatus · Nasdaq · CIK 704440 · FYE Dec 31 · Prices AT CLOSE 2026-07-29 (USD) — end-of-day, never a live or intraday quote
Last $4.07Day +1.50%Mkt cap $184M1Y +17.0%Off 52W high −38.4%Vol (1Y) 51.5%
Daily closing price, split-adjusted to the current basis; 3y shown of 5,290 bars on file. Sampled to 240 points — every point is a real close, none averaged. Price return, not total return (dividends excluded). Source marketstack.
| Short interest1.8% of sh out |
| Days to cover8.2d |
| 13F net flow (QoQ)−0.89% |
| Top-10 13F concentration76.7% |
| Next report (est.)2026-08-12 |
Short interest is FINRA semi-monthly, settlement 2026-07-15. 13F figures are quarterly filings, period 2026-Q1 — a lower bound on true ownership.
| Sales (TTM)$43.3M |
| Earnings (TTM)-$2.3M |
| ROE−15.6% |
| Net margin−6.4% |
| ROIC−30.5% |
| Sales growth 3Y13.8% |
Screener basis: ratios from the latest reported fiscal year; Sales/Earnings are trailing twelve months in the reporting currency (USD). The P/E is a trailing FULL-YEAR P/E, not TTM. Missing lines are absent from the filings, never imputed.
| YTD−29.9% |
| 1Y+17.0% |
| 3Y+56.5% |
| 5Y+18.7% |
| 10Y+766.0% |
| Since incept. (ann.)+18.7% |
Total return through 2026-07-29 · series begins 2005-07-11. Only the windows this history actually covers are shown.
| Ann. volatility (1Y)51.5% |
| Ann. volatility (3Y)58.3% |
| Sharpe (1Y)0.60 |
| Sharpe (3Y)0.53 |
| Max drawdown (1Y)−42.8% |
| Max drawdown (3Y)−58.0% |
| Beta (3Y vs SPY)1.30 |
Daily simple returns, annualized; drawdown is peak-to-trough within the window. Beta is the OLS slope of monthly returns on SPY's over three years. Each figure is labeled by the window it was measured over — they are not comparable across windows.
| Manager | Shares | Value | % sh out | QoQ |
|---|---|---|---|---|
| First Light Asset Management, LLC | 3.8M | $16M | 8.20% | −10.5% |
| Topline Capital Management, LLC | 3.5M | $15M | 7.65% | −10.8% |
| BlackRock, Inc. | 2.4M | $10M | 5.16% | −0.9% |
| VANGUARD CAPITAL MANAGEMENT LLC | 1.7M | $7M | 3.67% | new |
| GEODE CAPITAL MANAGEMENT, LLC | 1.1M | $5M | 2.29% | +2.8% |
| Simcoe Capital LLC | 811,247 | $4M | 1.77% | +20.2% |
| Meros Investment Management, LP | 760,451 | $3M | 1.66% | −2.8% |
| Empire Financial Management Company, LLC | 703,139 | $3M | 1.53% | +0.0% |
Reported 13F long positions as filed for 2026-Q1 (change vs 2025-Q4). 13F covers US-listed long equity only — the sum is a LOWER BOUND on institutional ownership, never a total.
| Period end | Reported | EPS | EPS YoY | Revenue | Rev YoY |
|---|---|---|---|---|---|
| 2026-03-31 | 2026-05-06 | −$0.02 | — | $11.8M | +22.1% |
| 2025-12-31 | 2026-03-12 | — | — | $10.9M | +23.3% |
| 2025-09-30 | 2025-11-12 | $0.02 | −33.3% | $10.4M | +27.2% |
| 2025-06-30 | 2025-08-06 | $0.00 | −100.0% | $10.2M | +20.9% |
EPS and revenue as reported in this filer's own XBRL — our extraction of the filings, not a vendor consensus feed, and never a beat/miss claim (we carry no estimates). YoY compares the same fiscal quarter a year earlier. Next report 2026-08-12 is ESTIMATED from filing cadence (median gap 98d) — not company-confirmed.
US 74% · Non Us 26%
geographic · each slice's share of TAGGED segment revenue in the latest annual filing (XBRL, as filed). Untagged revenue is excluded from the denominator, so slices need not sum to consolidated sales.
